AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beerbower, K. S.
Right arrow Articles by Raess, B. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beerbower, K. S.
Right arrow Articles by Raess, B. U.
Agricola
Right arrow Articles by Beerbower, K. S.
Right arrow Articles by Raess, B. U.

American Journal of Clinical Nutrition, Vol 41, 697-702, Copyright © 1985 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Erythrocyte, plasma, urine and dialysate zinc levels in patients on continuous ambulatory peritoneal dialysis

KS Beerbower and BU Raess

Abnormalities in zinc metabolism of patients with renal disease have been reported. However, accurate descriptions regarding zinc content in various biological compartments of a patient population on continuous ambulatory peritoneal dialysis (CAPD) including a dietary zinc intake assessment, are lacking. This study measured zinc content of erythrocytes, plasma, urine and dialysate in patients on CAPD, non- dialyzed chronically azotemic patients and a control group. Zinc and protein intake, serum albumin, protein and creatinine were quantified. Zinc analysis of erythrocytes, plasma, urine and dialysate was performed by atomic absorption spectrophotometry with special emphasis on immediate and complete separation of erythrocytes from plasma. Zinc levels in erythrocytes of patients on dialysis were increased whereas plasma zinc was slightly decreased compared to normal controls (p less than 0.05). It is concluded that zinc in CAPD patients is distributed similarly to non-dialyzed azotemic patients and that CAPD does not alter zinc distribution in erythrocytes and plasma.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by The American Society for Nutrition